Literature DB >> 19383516

The major cathepsin L secreted by the invasive juvenile Fasciola hepatica prefers proline in the S2 subsite and can cleave collagen.

Ileana Corvo1, Martín Cancela, Mónica Cappetta, Natalia Pi-Denis, José F Tort, Leda Roche.   

Abstract

Secreted cysteine proteases are major players in host-parasite interactions; in Fasciola hepatica, a distinct group of cathepsins L was found to be predominantly expressed in the juvenile stages, but their enzymatic properties were unknown. Cathepsin L3 (FhCL3) is a main component of the juvenile secretory products and may participate in invasion. To characterize the biochemical properties, the proenzyme was expressed in the methylotrophic yeast Hansenula polymorpha and the mature enzyme was obtained from the culture medium. FhCL3 exhibited optimal activity and stability at neutral pH and a noticeable restricted substrate specificity with 70-fold preference for Tos-Gly-Pro-Arg-AMC over typical cathepsin substrates with hydrophobic or aliphatic residues in the S2 position. Accordingly, FhCL3 efficiently cleaved type I collagen over different pH and temperature conditions, but it did not cleave immunoglobulin. While most cathepsin cysteine proteinases are unable to digest collagen, mammalian cathepsin K, adult F. hepatica FhCL2 and the plant zingipain can also cleave collagen and substrates with Pro in P2 position, but only FhCL3 and zingipain hydrolyze these substrates with the highest efficiency. Molecular modeling and structural comparisons of the collagen cleaving cathepsins indicated that the strong substrate selectivity observed might be due to steric restrictions imposed by bulky aromatic residues at the S2-S3 subsites. The remarkable similarities of the active site clefts highlight the evolutive constrains acting on enzyme function. The presence of a collagen cleaving enzyme in F. hepatica juvenile stages is suggestive of a role in tissue invasion, an essential feature for the establishment of the parasites in their host.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19383516     DOI: 10.1016/j.molbiopara.2009.04.005

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  23 in total

Review 1.  Juvenile-specific cathepsin proteases in Fasciola spp.: their characteristics and vaccine efficacies.

Authors:  Krai Meemon; Prasert Sobhon
Journal:  Parasitol Res       Date:  2015-06-24       Impact factor: 2.289

2.  Molecular characterization and determination of the biochemical properties of cathepsin L of Trichinella spiralis.

Authors:  Ruo Dan Liu; Xiang Yu Meng; Chen Le Li; Shao Rong Long; Jing Cui; Zhong Quan Wang
Journal:  Vet Res       Date:  2022-06-23       Impact factor: 3.829

3.  Survey of transcripts expressed by the invasive juvenile stage of the liver fluke Fasciola hepatica.

Authors:  Martín Cancela; Natalia Ruétalo; Nicolás Dell'Oca; Edileuza da Silva; Pablo Smircich; Gabriel Rinaldi; Leda Roche; Carlos Carmona; Fernando Alvarez-Valín; Arnaldo Zaha; José F Tort
Journal:  BMC Genomics       Date:  2010-04-07       Impact factor: 3.969

4.  Collagenolytic activities of the major secreted cathepsin L peptidases involved in the virulence of the helminth pathogen, Fasciola hepatica.

Authors:  Mark W Robinson; Ileana Corvo; Peter M Jones; Anthony M George; Matthew P Padula; Joyce To; Martin Cancela; Gabriel Rinaldi; Jose F Tort; Leda Roche; John P Dalton
Journal:  PLoS Negl Trop Dis       Date:  2011-04-05

5.  Design of a Peptide-Carrier Vaccine Based on the Highly Immunogenic Fasciola hepatica Leucine Aminopeptidase.

Authors:  Cecilia Salazar; José F Tort; Carlos Carmona
Journal:  Methods Mol Biol       Date:  2020

6.  Adaptive Radiation of the Flukes of the Family Fasciolidae Inferred from Genome-Wide Comparisons of Key Species.

Authors:  Young-Jun Choi; Santiago Fontenla; Peter U Fischer; Thanh Hoa Le; Alicia Costábile; David Blair; Paul J Brindley; Jose F Tort; Miguel M Cabada; Makedonka Mitreva
Journal:  Mol Biol Evol       Date:  2020-01-01       Impact factor: 16.240

7.  Fasciola hepatica vaccine: we may not be there yet but we're on the right road.

Authors:  Verónica Molina-Hernández; Grace Mulcahy; Jose Pérez; Álvaro Martínez-Moreno; Sheila Donnelly; Sandra M O'Neill; John P Dalton; Krystyna Cwiklinski
Journal:  Vet Parasitol       Date:  2015-01-15       Impact factor: 2.738

8.  Insights into the Interactions of Fasciola hepatica Cathepsin L3 with a Substrate and Potential Novel Inhibitors through In Silico Approaches.

Authors:  Lilian Hernández Alvarez; Dany Naranjo Feliciano; Jorge Enrique Hernández González; R O Soares; Rosemberg de Oliveira Soares; Diego Enry Barreto Gomes; Pedro Geraldo Pascutti
Journal:  PLoS Negl Trop Dis       Date:  2015-05-15

9.  Dissecting the active site of the collagenolytic cathepsin L3 protease of the invasive stage of Fasciola hepatica.

Authors:  Ileana Corvo; Anthony J O'Donoghue; Lucía Pastro; Natalia Pi-Denis; Alegra Eroy-Reveles; Leda Roche; James H McKerrow; John P Dalton; Charles S Craik; Conor R Caffrey; José F Tort
Journal:  PLoS Negl Trop Dis       Date:  2013-07-11

10.  Tegument Glycoproteins and Cathepsins of Newly Excysted Juvenile Fasciola hepatica Carry Mannosidic and Paucimannosidic N-glycans.

Authors:  Andres Garcia-Campos; Alessandra Ravidà; D Linh Nguyen; Krystyna Cwiklinski; John P Dalton; Cornelis H Hokke; Sandra O'Neill; Grace Mulcahy
Journal:  PLoS Negl Trop Dis       Date:  2016-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.